MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease…
MaaT PharmaJuly 2, 2025
© 2026 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases
